Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Cash Flow Reinvestment Rate
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Cash Flow Reinvestment Rate of 0.52x as of September 2025, reinvesting CN¥30.63 Million (capex CN¥30.63 Million ) from operating cash flow of CN¥58.54 Million. See Sichuan Huiyu Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Sichuan Huiyu Pharmaceutical Co Ltd across 7 annual periods. For the full cash flow conversion analysis, see 688553 cash flow conversion.
Annual Cash Flow Reinvestment Rate for Sichuan Huiyu Pharmaceutical Co Ltd (2018–2024)
Year-by-year capital reinvestment analysis for Sichuan Huiyu Pharmaceutical Co Ltd. See 688553 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.17x | CN¥526.72 Million | CN¥242.96 Million | CN¥128.18 Million | ▼ -82.4% |
| 2023 | 12.35x | CN¥826.75 Million | CN¥66.93 Million | CN¥296.72 Million | ▲ +273.0% |
| 2022 | 3.31x | CN¥642.65 Million | CN¥194.06 Million | CN¥461.61 Million | ▼ -35.9% |
| 2021 | 5.17x | CN¥2.31 Billion | CN¥446.36 Million | CN¥433.45 Million | ▲ +421.4% |
| 2020 | 0.99x | CN¥384.33 Million | CN¥387.95 Million | CN¥158.24 Million | ▼ -16.9% |
| 2019 | 1.19x | CN¥388.90 Million | CN¥326.22 Million | CN¥110.00 Million | ▲ +567.8% |
| 2018 | 0.18x | CN¥23.04 Million | CN¥129.06 Million | CN¥23.04 Million | — |